Last reviewed · How we verify
cypermethrin
cypermethrin is a cypermethrin drug. It is currently in unknown development.
Cypermethrin works by binding to insect voltage-gated sodium channels, preventing the normal flow of sodium ions and disrupting the insect's nervous system.
Cypermethrin is a synthetic pyrethroid insecticide originally developed by ICI (now part of Syngenta), a small molecule belonging to the drug class of cypermethrin. Its exact target and mechanism of action are not well-documented, but it is known to disrupt insect nervous systems. Cypermethrin is not FDA-approved for human use, and its commercial status is primarily as a pesticide. Key safety considerations include potential neurotoxicity and environmental contamination. As a pesticide, it is not intended for human therapeutic use.
At a glance
| Generic name | cypermethrin |
|---|---|
| Drug class | cypermethrin |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine your nerves are like a highway system, and sodium ions are like cars driving on that highway. Cypermethrin blocks the sodium ions from driving on the highway, which prevents the insect's nerves from functioning properly and ultimately kills the insect.
Approved indications
Common side effects
Key clinical trials
- Net Transition Initiative: Efficacy of Two Next-generation Nets for Control of Malaria in Cote d'Ivoire (NA)
- Chronic Diseases in Primary Care (NA)
- ANEURYSM@RISK: Automatic Intracranial Aneurysm Quantification and Feature Learning Modelling to Optimize Intracranial Aneurysm Rupture Prediction
- Efficacy of Three Novel Bi-treated Long Lasting Insecticidal Nets (NA)
- LLIN Evaluation in Uganda Project (NA)
- Efficacy of Two Dual Active Ingredient Long Lasting Insecticidal Nets for Control of Malaria Transmitted by Pyrethroid Resistant Vectors in Benin (NA)
- Validating Digital Biomarkers to Detect Disease Activity and Disease Progression in Multiple Sclerosis
- Multiple Sclerosis Self Monitoring Study (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- cypermethrin CI brief — competitive landscape report
- cypermethrin updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about cypermethrin
What is cypermethrin?
How does cypermethrin work?
What drug class is cypermethrin in?
What development phase is cypermethrin in?
Related
- Drug class: All cypermethrin drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing